@article{22750,
      note = {- The issue of admissibility of clinical trials related to  pharmaceutically active ingredients petented to third  parties and eventually aimed also at obtaining regulatory  marketing authorization since some years has attracted  enormous attention. This is witnessed by a remarkable  number of court decisions handed down in various countries,  by numerous articles published in leading law and economic  journals, as well as by legal actions initiated with the  World Trade Organization (WTO);.},
      author = {Straus, Joseph,},
      url = {http://tind.wipo.int/record/22750},
      title = {On the admissibility of Biological Equivalence Tests  during the patent term for obtaining a regulatory approval  for patented drugs by third parties : a study in German and  comparative /},
      recid = {22750},
      pages = {1 volume ([35] pages) ;},
}